Current Treatment Options in Oncology

Papers
(The median citation count of Current Treatment Options in Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Treatment of Relapsed Acute Myeloid Leukemia131
Targeted Therapies in Advanced Gastric Cancer120
Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines55
Metabolic Aspects of Anthracycline Cardiotoxicity45
Tumor Treating Fields in the Management of Patients with Malignant Gliomas44
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma41
Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape37
Models of Integration of Specialized Palliative Care with Oncology36
Advances in the Treatment of Cardiac Amyloidosis36
The Effect of Prognostic Communication on Patient Outcomes in Palliative Cancer Care: a Systematic Review35
Systemic Therapy for Metastatic Pancreatic Cancer33
Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates33
Mycosis Fungoides and Sézary Syndrome: Updates and Review of Current Therapy32
The Importance of Prognostication: Impact of Prognostic Predictions, Disclosures, Awareness, and Acceptance on Patient Outcomes31
Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations30
When to Integrate Palliative Care in the Trajectory of Cancer Care29
New Treatment Options for Advanced Biliary Tract Cancer27
PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma26
Optimal Strategies for Colorectal Cancer Screening26
Immunotherapy in Hepatocellular Carcinoma25
Leptomeningeal Metastases in Non-small Cell Lung Cancer: Optimal Systemic Management in NSCLC With and Without Driver Mutations25
Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer24
Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma24
Defining and Targeting BRAF Mutations in Solid Tumors23
Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults23
Optimal Management of Corticosteroids in Patients with Intracranial Malignancies22
Contemporary Management of Anaplastic Thyroid Cancer22
Curative-Intent Therapies in Localized Hepatocellular Carcinoma21
Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy21
Current Treatment of Melanoma Brain Metastasis21
Cardiovascular Toxicities of Androgen Deprivation Therapy20
BRAF Heterogeneity in Melanoma20
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms20
Immunotherapy Alone or in Combination with Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer19
Current Management of Angiosarcoma: Recent Advances and Lessons From the Past19
Oncolytic Viruses for the Treatment of Metastatic Melanoma19
Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy19
Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone18
Janus Kinase Inhibitors and Non-Melanoma Skin Cancer18
Radiation Necrosis from Stereotactic Radiosurgery—How Do We Mitigate?18
Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer18
Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy18
Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma17
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives17
Systemic Options for Malignant Peripheral Nerve Sheath Tumors16
Appropriate Selection of PARP Inhibitors in Ovarian Cancer16
BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies16
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer16
Progress on Management of Penile Cancer in 202016
Understanding and Supporting Informal Cancer Caregivers16
Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment16
Evaluation and Management of Sleep and Circadian Rhythm Disturbance in Cancer15
The Evolving Landscape of HER2-Directed Breast Cancer Therapy15
Current Status of CAR T Cell Therapy for Leukemias15
Cardiotoxicity of Radiation Therapy: Mechanisms, Management, and Mitigation15
Role of TKI for Metastatic Osteogenic Sarcoma15
Re-evaluation of Sentinel Lymph Node Biopsy for Melanoma15
Role of Laser Interstitial Thermal Therapy in the Management of Primary and Metastatic Brain Tumors15
The Potential of Immune Checkpoint Blockade in Cervical Cancer: Can Combinatorial Regimens Maximize Response? A Review of the Literature14
Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches14
Constipation in Cancer Patients — an Update of Clinical Evidence14
Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?14
Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?14
Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?14
Symptom Management in Pancreatic Cancer13
Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma13
Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy13
Late and Long-Term Treatment-Related Effects and Survivorship for Head and Neck Cancer Patients13
Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms13
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms13
Leveraging Social Media for Cardio-Oncology13
Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients12
Update on First-Line Combination Treatment Approaches in Metastatic Clear-Cell Renal Cell Carcinoma12
Treatment Strategies for Oligometastatic Breast Cancer12
New Approaches to Myelodysplastic Syndrome Treatment12
Refining Immuno-Oncology Approaches in Metastatic Prostate Cancer: Transcending Current Limitations12
Family Meetings in Palliative Care: Benefits and Barriers12
Treatment for Oral Mucositis—Current Options and an Update of Small Molecules Under Development12
Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy12
Localized Non-melanoma Skin Cancer: Risk Factors of Post-surgical Relapse and Role of Postoperative Radiotherapy12
HER2-Directed Therapy in Advanced Gastric and Gastroesophageal Adenocarcinoma: Triumphs and Troubles12
Treating Chronic Pain with Buprenorphine—The Practical Guide12
The Benefits of Olanzapine in Palliating Symptoms12
Biomarkers in Neuroblastoma: An Insight into Their Potential Diagnostic and Prognostic Utilities11
TRK Inhibitors in Non-Small Cell Lung Cancer11
Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?11
Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis11
Immunotherapy and Biomarkers in Sarcoma11
Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?11
Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects11
Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors11
Management of Laryngeal Dysplasia and Early Invasive Cancer11
Exercise Training for Cancer Survivors11
Strategies to Prevent Cardiotoxicity11
Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy11
Systemic Therapy for Lung Cancer Brain Metastases11
Treatment personalization in gastrointestinal neuroendocrine tumors10
Recent and Emerging Therapies for Cutaneous Squamous Cell Carcinomas of the Head and Neck10
New Treatment Options for Older Patients with Acute Myeloid Leukemia10
Drug Repurposing in Medulloblastoma: Challenges and Recommendations10
Surgical Management of Skull Base and Spine Chordomas10
The Role of Oncoplastic Surgery for Breast Cancer10
Robotic Surgery in Rectal Cancer: Potential, Challenges, and Opportunities10
Patient Selection and Toxicities of PRRT for Metastatic Neuroendocrine Tumors and Research Opportunities10
Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas10
Metastatic Adenoid Cystic Carcinoma: Genomic Landscape and Emerging Treatments10
BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia10
Immunotherapy in Gastroesophageal Cancers: Current Evidence and Ongoing Trials10
New Treatment Strategies for the Inflammatory Breast Cancer10
How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell Failure10
Targeting the FGFR Pathway in Urothelial Carcinoma: the Future Is Now10
Hereditary Syndromes in Neuroendocrine Tumors10
Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer10
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma9
Advanced Acral Melanoma Therapies: Current Status and Future Directions9
Defining and Treating Borderline Resectable Pancreatic Cancer9
Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma9
Cardiovascular Issues in Hematopoietic Stem Cell Transplantation (HSCT)9
Anatomic and Functional Imaging of Neuroendocrine Tumors9
Interventional Liver-Directed Therapy for Neuroendocrine Metastases: Current Status and Future Directions9
Treatment Approach to Adenocarcinoma of the Ampulla of Vater9
Current Challenge: Endoscopic Submucosal Dissection of Superficial Non-ampullary Duodenal Epithelial Tumors9
New Strategies and Novel Combinations in EGFR TKI-Resistant Non-small Cell Lung Cancer9
Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer8
Immunotherapy in Small Cell Lung Cancer Treatment: a Promising Headway for Future Perspective8
Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers8
Targeted Therapy for Melanomas Without BRAF V600 Mutations8
Options for the Treatment of Mucinous Ovarian Carcinoma8
New Immuno-oncology Targets and Resistance Mechanisms8
Promising Blood-Based Biomarkers for Melanoma: Recent Progress of Liquid Biopsy and Its Future Perspectives8
Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic8
Drug Development in Neuroendocrine Tumors: What Is on the Horizon?8
A Review of Pharmacologic Management in the Treatment of Mesothelioma8
Integrating Palliative Care into Oncology Care Worldwide: The Right Care in the Right Place at the Right Time8
Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection8
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer8
Nectin-4: a Novel Therapeutic Target for Skin Cancers8
Management of Myelofibrosis: from Diagnosis to New Target Therapies8
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?7
Molecular-Driven Therapy in Advanced Thyroid Cancer7
Clinical Development of PD-1/PD-L1 Inhibitors in Breast Cancer: Still a Long Way to Go7
Myxoid Liposarcoma: How to Stage and Follow7
Perioperative Chemotherapy for Liver Metastasis of Colorectal Cancer: Lessons Learned and Future Perspectives7
Cardiovascular Toxicities of Bruton’s Tyrosine Kinase Inhibitors7
The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer7
The Role of Epithelial-to-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma7
Approach to Localized Squamous Cell Cancer of the Esophagus7
Biology and Treatment of Hairy Cell Leukemia7
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity7
New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease7
HER2-Low Breast Cancer: a New Subtype?7
Contemporary Use of Hormonal Therapy in Endometrial Cancer: a Literature Review7
Management of Cutaneous Angiosarcoma: an Update Review7
Postoperative Management of Salivary Gland Tumors7
The Importance of Primary Care in Cardio-Oncology7
Complex Persistent Opioid Dependence—an Opioid-induced Chronic Pain Syndrome7
Tailoring Treatment for Patients with Inflammatory Breast Cancer7
Current Treatment Options for Older Patients with Hodgkin Lymphoma7
Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer7
Recurrent Treatment in Ovarian Cancer Patients: What Are the Best Regimens and the Order They Should Be Given?7
Circulating Biomarkers for Cardiotoxicity Risk Prediction7
Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer7
Systemic Therapy for Chondrosarcoma6
Radical Hysterectomy for Cervical Cancer: the Right Surgical Approach6
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer6
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies6
Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light6
Personalizing the Setting of Palliative Care Delivery for Patients with Advanced Cancer: “Care Anywhere, Anytime”6
Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges6
Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy6
Systemic and Targeted Therapies in Adenoid Cystic Carcinoma6
State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors6
The Role of Biomarkers to Evaluate Cardiotoxicity6
Dermatofibrosarcoma Protuberans in Children6
Health-Related Quality of Life and Patient-Reported Outcomes in Radiation Oncology Clinical Trials6
Novel Therapies in the Treatment of Hodgkin Lymphoma6
Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma6
Surveillance and Monitoring Techniques for HPV-Related Head and Neck Squamous Cell Carcinoma: Circulating Tumor DNA6
Approach to Resectable Biliary Cancers6
Immune Checkpoint Inhibitors for the Treatment of Gestational Trophoblastic Neoplasia: Rationale, Effectiveness, and Future Fertility6
The Role of Pharmacogenomics in Opioid Prescribing6
Novel Therapies for Follicular Lymphoma and Other Indolent Non-Hodgkin Lymphomas6
Cancer Therapies and Vascular Toxicities6
Consolidation Therapy in Primary Central Nervous System Lymphoma6
Therapeutic and Supportive Effects of Cannabinoids in Patients with Brain Tumors (CBD Oil and Cannabis)6
Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma6
The Role of Radiation Therapy for Symptomatic Desmoid Tumors6
Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors6
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours6
Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma5
Use of Robotics in Surgical Treatment of Non-small Cell Lung Cancer5
Available Therapies for Patients with Neurofibromatosis-Related Nervous System Tumors5
Targeting KRASp.G12C Mutation in Advanced Non-Small Cell Lung Cancer: a New Era Has Begun5
Molecular Determinants and Other Factors to Guide Selection of Patients for Hepatic Resection of Metastatic Colorectal Cancer5
Gastrointestinal Stromal Tumors: What Is the Best Sequence of TKIs?5
Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions5
Immunotherapy in HPV-Related Oropharyngeal Cancers5
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?5
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy5
Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic5
How to Sequence Therapies in Waldenström Macroglobulinemia5
Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence5
New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE)5
Approach to the Patient with Unknown Primary Squamous Cell Carcinoma of the Head and Neck5
Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments5
Hypomethylating Agents in Lymphoma5
Management of Fatigue in Patients with Advanced Cancer5
Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer?5
Should Loss of Appetite Be Palliated in Patients with Advanced Cancer?5
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?5
Progress in the Treatment of Small Intestine Cancer5
An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN)5
Antibody–Drug Conjugate Revolution in Breast Cancer: The Road Ahead5
Acute Myeloid Leukemia Mutations and Future Mechanistic Target to Overcome Resistance5
Which FLT3 Inhibitor for Treatment of AML?5
Central Nervous System Lymphoma: Novel Therapies4
Approach to Resectable Gastric Cancer: Evolving Paradigm of Neoadjuvant and Adjuvant Treatment4
Targeted Therapy for BRAF Mutant Brain Tumors4
The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer4
Novel Estrogen Receptor-Targeted Agents for Breast Cancer4
Indications for Allogeneic HCT in Adults with Acute Lymphoblastic Leukemia in First Complete Remission4
Surgical Management of Metastatic Gastrointestinal Stromal Tumors4
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges4
New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic Leukemia4
Overview and Emerging Trends in the Treatment of Osteoradionecrosis4
Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies4
Multidisciplinary Management of Brain Metastases from Non-Small Cell Lung Cancer in the Era of Immunotherapy4
Surgery Matters: Progress in Surgical Management of Gastric Cancer4
Understanding the Clinical Implications of Low Penetrant Genes and Breast Cancer Risk4
Radical Hysterectomy After the LACC Trial: Back to Radical Vaginal Surgery4
The Current Landscape of Research Advocacy and Education for Patients with Colorectal Cancer4
Treatment Strategies for Malignancies of the External Auditory Canal4
COVID-19 and Gynecologic Oncology: What Have We Learned?4
The Role of Laparoscopic Surgery in Localized Pancreatic Neuroendocrine Tumours4
Novel Approaches for the Treatment of Patients with Richter’s Syndrome4
Advances in Organ Preservation for Laryngeal Cancer4
Selection of Oral Therapeutics in China for the Treatment of Colorectal Cancer4
Future Strategies Involving Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma4
ctDNA to Guide Treatment of Colorectal Cancer: Ready for Standard of Care?4
Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice4
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T4
Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma4
Current Management and Treatment of Extramammary Paget’s Disease4
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)4
Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer4
In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia4
Cardio-oncology Training in the COVID-19 Era4
Pathogenic Mechanisms in Acute Myeloid Leukemia4
Targeted Therapy in Early Stage Non-small Cell Lung Cancer4
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?4
0.030178070068359